PepGen Shares Quarterly Newsletter

April 10, 2023

On April 7, 2023, PepGen shared a quarterly newsletter which announces that their Phase 2 DMD trials, Connect1-EDO51 and Connect2-EDO51, are planned to start this year and more.

To view PepGen’s quarterly newsletter, please click here.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open